The Lancet: April 04, 2008

Doubts over the long-term safety of the HIV nucleoside reverse transcriptase inhibitor abacavir and the less commonly used antiretroviral drug didanosine are raised in a research Article. Both drugs were found to be associated with an increased risk of myocardial infarction. Jens Lundgren (University of Copenhagen, Denmark) discusses the study in this week's podcast.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps...